Increased NAMPT levels have been previously associated with worse prognosis in pancreatic cancer patients [58,59] and we found that both NAMPT and NAPRT, other important enzyme involved in NAD biosynthesis, are upregulated in tumor pancreatic samples of different databases, leading to a decreased survival probability of pancreatic cancer patients. Here, NAPRT is linked to familial pancreatic carcinoma.